Home > Financial Ratios > MEDICO REMEDIES

MEDICO REMEDIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for MEDICO REMEDIES
Please provide your vote to see the results

MEDICO REMEDIES Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 29.7817.6510.8544.8949.34

What is the latest Core EBITDA Growth ratio of MEDICO REMEDIES ?

The latest Core EBITDA Growth ratio of MEDICO REMEDIES is 29.78 based on Mar2026 Standalone results.
Year Core EBITDA Growth
Mar202629.78
Mar202517.65
Mar202410.85
Mar202344.89
Mar202249.34

How is Core EBITDA Growth of MEDICO REMEDIES Trending?

Years Core EBITDA Growth % Change
Mar2026 29.78
68.73
Mar2025 17.65
62.67
Mar2024 10.85
-75.83
Mar2023 44.89
-9.02
Mar2022 49.34 -

Other Financial Ratios of MEDICO REMEDIES


Compare Core EBITDA Growth ratio of peers of MEDICO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICO REMEDIES ₹188.7 Cr 4.1% -42.6% -56.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,251.0 Cr -2% -6.1% 33% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics


MEDICO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICO REMEDIES

4.1%

-42.6%

-56.3%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses